Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Nutr Neurosci ; 25(2): 246-255, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32264793

RESUMEN

Background: Weight homeostasis is complex in Parkinson's disease (PD) and body weight changes substantially throughout the course of the disease. We designed a case-control study to (i) investigate whether PD is associated with changes in resting energy expenditure (REE), (ii) to assess how accurately REE could be predicted for individuals with PD utilizing the equations constructed for healthy individuals, and (iii) to eventually construct a new equation.Materials & Methods: Measured REE (mREE) was compared between 122 PD patients and 122 gender and body mass index (BMI)-matched controls. The accuracy of estimated REE by 5 common equations (Harris/Benedict-1919, Roza/Shizgal-1984, Mifflin St. Jeor, WHO/FAO and aggregate formula) was investigated in PD using Bland-Altman analysis and reported as the frequency of accurate predictions (±10%). Concordance correlation coefficients (CCC) were also calculated. Then, we regressed a new REE equation - using gender, age, weight, height and Hoehn-Yahr stage - and validated it in an independent sample (N = 100).Results: No significant difference in mREE was recorded between the whole PD sample and healthy controls. However, mREE was increased in patients with BMI ≥ 30 kg/m2 and Hoehn-Yahr stage ≥ 3. Limited accuracy was present in the available REE equations (accurate prediction [±10%] frequency, <60% for all). For the new equation, the proportion of accurate prediction was 67.0% (overestimation, 24.0%) and CCC was 0.77.Conclusion: PD patients are not commonly characterized by an increase in REE. This is limited to patients suffering from obesity and more severe disease. Common REE equations appear to be inaccurate. The new predictive equation proposed in this study provided better REE estimates.


Asunto(s)
Enfermedad de Parkinson , Metabolismo Basal , Índice de Masa Corporal , Calorimetría Indirecta , Estudios de Casos y Controles , Metabolismo Energético , Humanos , Enfermedad de Parkinson/tratamiento farmacológico , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados
2.
Int J Food Sci Nutr ; 70(1): 107-115, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29792366

RESUMEN

In Zambia, chronic malnutrition still is one of the most common problem among children. To fight against malnutrition, the easiest short-term solution could be to combine specific types of food with affordable local plants. A large variety of natural food resources grow in Zambia, such as Moringa oleifera (MO), whose leaves are known for their health benefits, but are not consumed much by local populations. We analysed Zambian MO powder obtained from dried leaves and found that it contains large amounts of protein, minerals and vitamins, such as iron, calcium and carotenoids. These characteristics make MO a good and sustainable complementary solution to malnutrition. We also evaluated the acceptability and the safety of dietary supplementation with MO powder in malnourished children for 30 days. A daily dose of 14 g daily was safe and well accepted. Its regular use in the menu of local populations may be viable proposition.


Asunto(s)
Suplementos Dietéticos , Desnutrición/dietoterapia , Moringa oleifera/química , Valor Nutritivo , Adolescente , Antropometría , Composición Corporal , Estudios de Casos y Controles , Niño , Preescolar , Dieta , Femenino , Humanos , Desnutrición/etiología , Desnutrición/prevención & control , Minerales/análisis , Hojas de la Planta/química , Polvos , Seguridad , Vitaminas/análisis , Zambia
3.
Mov Disord ; 34(3): 396-405, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30576008

RESUMEN

BACKGROUND: Although several studies have suggested that abnormalities in gut microbiota may play a critical role in the pathogenesis of PD, data are still extremely heterogeneous. METHODS: 16S gene ribosomal RNA sequencing was performed on fecal samples of 350 individuals, subdivided into idiopathic PD (n = 193, of whom 39 were drug naïve) stratified by disease duration, PSP (n = 22), MSA (n = 22), and healthy controls (HC; n = 113). Several confounders were taken into account, including dietary habits. RESULTS: Despite the fact that unadjusted comparison of PD and HC showed several differences in relative taxa abundances, the significant results were greatly reduced after adjusting for confounders. Although most of these differences were associated with disease duration, lower abundance in Lachnospiraceae was the only difference between de novo PD and HC (remaining lower across almost all PD duration strata). Decreased Lachnospiraceae and increased Lactobacillaceae and Christensenellaceae were associated with a worse clinical profile, including higher frequencies of cognitive impairment, gait disturbances, and postural instability. When compared with HC, MSA and PSP patients shared the changes in PD, with a few exceptions: in MSA, Lachnospiraceae were not lower, and Prevotellaceae were reduced; in PSP, Lactobacillaceae were similar, and Streptococcaceae were reduced. CONCLUSIONS: Gut microbiota may be an environmental modulator of the pathogenesis of PD and contribute to the interindividual variability of clinical features. Data are influenced by PD duration and several confounders that need to be taken into account in future studies. Prospective studies in de novo PD patients are needed to elucidate the net effect of dysbiosis on the progression of the disease. © 2018 International Parkinson and Movement Disorder Society.


Asunto(s)
Microbioma Gastrointestinal/fisiología , Enfermedad de Parkinson/microbiología , Trastornos Parkinsonianos/microbiología , Anciano , Estudios de Casos y Controles , Progresión de la Enfermedad , Heces/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Atrofia de Múltiples Sistemas/microbiología , Parálisis Supranuclear Progresiva/microbiología
4.
Parkinsonism Relat Disord ; 42: 40-46, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28647435

RESUMEN

INTRODUCTION: Our objective is to describe the dietary habits, food preferences and adherence to Mediterranean diet (MeDi) of a large sample of Italian Parkinson's Disease (PD) patients compared to a group of controls. METHODS: Dietary habits of 600 PD patients from throughout Italy and 600 controls matched by gender, age, education, physical activity level and geographical residence, were collected using the ON-GP Food Frequency Questionnaire. Then, we compared patients by disease duration and the presence of swallowing disturbances. RESULTS: Overall, adherence of PD patients (males, 53.8%; mean disease duration, 9.2 ± 7.0 years) to MeDi was similar to controls (score, 4.8 ± 1.7 vs. 4.9 ± 1.6; P = 0.294). Patients consumed less alcohol and fish and drank significantly less water, coffee, and milk which resulted also in lower total fluids intake. On the contrary, they ate more fruit, cooked vegetables, cereals and baked items, more dressings and more sweets in general. Disease duration was associated with increased intake of several food groups but it was not associated with changes in MeDi score (P = 0.721). Patients with swallowing disturbances (n = 72) preferred softer and more viscous food but preferences did not result in differences in dietary pattern. However, patients with dysphagia drank less fluids (P = 0.043). DISCUSSION: PD patients presented different dietary habits and food preferences compared to the general population and adherence to MeDi was not associated with disease duration. Self-reported dysphagia was associated with reduced intake of fluids. These aspects may be amenable to change in order to improve the management of nutritional issues in this patient population.


Asunto(s)
Dieta Mediterránea , Conducta Alimentaria , Conocimientos, Actitudes y Práctica en Salud , Enfermedad de Parkinson/fisiopatología , Enfermedad de Parkinson/psicología , Anciano , Análisis de Varianza , Estudios de Casos y Controles , Trastornos de Deglución/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
5.
Clin Nutr ; 36(4): 1054-1061, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-27406858

RESUMEN

BACKGROUND & AIMS: Parkinson's disease (PD) patients can benefit considerably from appropriate nutritional care, particularly from diet. However, there is limited evidence on the eating habits of PD patients and their relationship with the features of the disease. METHODS: We conducted a large case-control study. Consecutive PD patients (N = 600) receiving systematic nutritional care and healthy controls (N = 600) matched (1:1) for age, gender, education, physical activity level and residence were studied using a 66-item food frequency questionnaire. The relationship between dietary habits and the following features of PD were investigated in patients: body weight, energy balance, constipation, and levodopa therapy (dose) and its related motor complications. RESULTS: PD patients had lower BMI and reported higher food intake than controls. BMI was found to be inversely associated with disease duration and severity, and levodopa-related motor complications, whereas energy intake was positively associated with these variables. An increase in protein intake by 10 g over physiological requirements (0.8 g/kg/day) corresponded to a mean increase in levodopa dose of 0.7 mg/kg/day. Constipation was also associated with higher levodopa requirements. Finally, protein intake and its distribution throughout the day influenced levodopa-related motor complications. CONCLUSION: The management of protein intake and the treatment of constipation should be considered to be an integral part of the care of PD patients. Attention should always be focused on energy intake also. This would result in the maintenance of nutritional status, the optimization of levodopa-therapy and the minimization of its related motor complications.


Asunto(s)
Estreñimiento/etiología , Dieta Saludable , Ingestión de Energía , Conducta Alimentaria , Desnutrición/etiología , Enfermedad de Parkinson/fisiopatología , Cooperación del Paciente , Anciano , Antiparkinsonianos/administración & dosificación , Antiparkinsonianos/efectos adversos , Antiparkinsonianos/uso terapéutico , Estudios de Casos y Controles , Estreñimiento/epidemiología , Estudios Transversales , Femenino , Interacciones Alimento-Droga , Hospitales Especializados , Humanos , Italia/epidemiología , Levodopa/administración & dosificación , Levodopa/efectos adversos , Levodopa/uso terapéutico , Masculino , Desnutrición/epidemiología , Persona de Mediana Edad , Servicio Ambulatorio en Hospital , Enfermedad de Parkinson/tratamiento farmacológico , Prevalencia , Riesgo , Índice de Severidad de la Enfermedad
6.
Neurology ; 87(12): 1274-80, 2016 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-27543643

RESUMEN

OBJECTIVES: Our objective was to evaluate the efficacy of probiotics and prebiotics in patients with Parkinson disease (PD) and constipation. METHODS: We conducted a tertiary setting, randomized, double-blind, placebo-controlled trial in patients with PD with Rome III-confirmed constipation based on 2-week stool diary data at baseline. Patients (n = 120) were randomly assigned (2:1) to either a fermented milk, containing multiple probiotic strains and prebiotic fiber, or placebo, once daily for 4 weeks. The primary efficacy endpoint was the increase in the number of complete bowel movements (CBMs) per week. The key secondary endpoints were 3 or more CBMs and an increase by one or more CBMs per week during weeks 3 and 4. RESULTS: For the primary endpoint, the consumption of a fermented milk containing probiotics and prebiotics resulted in a higher increase in the number of CBMs (mean 1.2, 95% confidence interval [CI] 0.8-1.6) than placebo (0.1, 95% CI -0.4% to 0.6%) (mean difference 1.1, 95% CI 0.4-1.8; p = 0.002). For the key secondary endpoints, a higher number of patients in the probiotics-prebiotics group vs the placebo group reported 3 or more CBMs (p = 0.030; 58.8% vs 37.5%; odds ratio = 2.4, 95% CI 1.1-5.2) and an increase by one or more CBMs (p = 0.004; 53.8% vs 25.0%; odds ratio = 3.5, 95% CI 1.8-8.1) during weeks 3 and 4. CONCLUSIONS: The consumption of a fermented milk containing multiple probiotic strains and prebiotic fiber was superior to placebo in improving constipation in patients with PD. CLINICALTRIALSGOV IDENTIFIER: NCT02459717. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for patients with PD who have constipation, fermented milk containing probiotics and prebiotics increases the frequency of CBMs.


Asunto(s)
Estreñimiento/dietoterapia , Leche , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/dietoterapia , Prebióticos/administración & dosificación , Probióticos/administración & dosificación , Anciano , Animales , Estreñimiento/etiología , Defecación , Método Doble Ciego , Femenino , Humanos , Masculino , Pacientes Ambulatorios , Satisfacción del Paciente , Prebióticos/efectos adversos , Probióticos/efectos adversos , Índice de Severidad de la Enfermedad , Centros de Atención Terciaria , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA